JiMED
Experience seamless communication with our AI-powered wireless implant for ALS sufferers that reads brain activity, enhancing quality of life.
Experience seamless communication with our AI-powered wireless implant for ALS sufferers that reads brain activity, enhancing quality of life.
JiMED is a pioneering startup that aims to revolutionize the way ALS patients communicate and interact with the world. Established in 2020, the company's slogan, "Experience seamless communication with our AI-powered wireless implant for ALS sufferers that reads brain activity, enhancing quality of life," encapsulates its core mission. JiMED's innovative platform offers a wireless embedded BCI system that interprets brain activity, enabling individuals with ALS to operate devices through thought, thereby significantly improving their quality of life.
The latest milestone for JiMED came on 31 March 2021 with a significant ¥200.00M Venture Round investment. The investors involved in this round were Mizuho Capital and Osaka University Venture Capital, organizations with a strong track record in recognizing and supporting groundbreaking technological advancements.
Through its groundbreaking approach, JiMED not only presents a compelling investment opportunity but also promises to make a profound impact on the lives of ALS patients, addressing a critical need in the healthcare industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | ¥200.00M | 2 |
|
31 Mar 2021 |
No recent news or press coverage available for JiMED.
We care about your data, and we'd love to use cookies make your experience better.